SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

NCT00180453 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Everolimus
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis

Interventions

DEVICE: Coronary artery drug eluting stent placement
DEVICE: Coronary artery stent placement

Sponsor

Abbott Medical Devices